Serotonin-norepinephrine reuptake inhibitor
Showing 1 - 25 of 8,645
Major Depressive Disorder Who Have HadInadequate Response
Terminated
- Depressive Disorder, Major
- Standard of Care (SOC)
-
San Francisco, California
- +3 more
Dec 6, 2022
Major Depressive Disorder With Anhedonia and Inadequate Response
Not yet recruiting
- Depressive Disorder, Major
- No Intervention
- (no location specified)
Apr 24, 2023
Depression in Old Age, Fragility Fracture Trial in Winston-Salem (Duloxetine 30 mg)
Not yet recruiting
- Depression in Old Age
- Fragility Fracture
- Duloxetine 30 mg
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
May 9, 2023
Risk Factors for AD-Associated Switch to Mania
Completed
- Bipolar Disorder
- Selective Serotonin Reuptake Inhibitors (SSRI), Serotonin-Norepinephrine Reuptake Inhibitor( SNRI), and Tricyclics.
-
Barcelona, Catalonia, SpainHospital Clinic Barcelona
Nov 17, 2021
Tibial Plateau Fracture, Pain, Postoperative Trial in Boston, Valhalla (Duloxetine, Placebo, Standard of care (SOC) for tibial
Not yet recruiting
- Tibial Plateau Fracture
- Pain, Postoperative
- Duloxetine
- +2 more
-
Boston, Massachusetts
- +1 more
Aug 6, 2022
Meniere Disease Trial in Charleston (Venlafaxine, Placebo oral tablet)
Recruiting
- Meniere Disease
- Venlafaxine
- Placebo oral tablet
-
Charleston, South CarolinaMedical Univeristy of South Carolina
Dec 2, 2021
Depression, MDD, Dysthymic Disorder Trial in Indianapolis (behavioral, drug, other)
Completed
- Depression
- +7 more
- Beating the Blues (BtB)
- +3 more
-
Indianapolis, IndianaIUPUI Department of Psychology
Aug 30, 2021
PTSD Trial in United States (Selective serotonin reuptake inhibitor, Serotonin-norepinephrine reuptake inhibitor, Written
Recruiting
- PTSD
- Selective serotonin reuptake inhibitor
- +2 more
-
North Little Rock, Arkansas
- +15 more
Aug 2, 2022
None (i.e. Healthy Volunteers) Trial in Ottawa (Levomilnacipran, Duloxetine, Placebos)
Active, not recruiting
- None (i.e. Healthy Volunteers)
- Levomilnacipran
- +2 more
-
Ottawa, Ontario, CanadaInstitute of Mental Health Research, Royal Ottawa Mental Health
Oct 5, 2021
Depressive Disorder, Major Trial in United States (JNJ-42847922, Placebo Matching to JNJ-42847922, Quetiapine XR)
Generalized Anxiety Disorder Trial in Toronto (Desvenlafaxine)
Completed
- Generalized Anxiety Disorder
-
Toronto, Ontario, CanadaSTART Clinic for Mood and Anxiety Disorders
Oct 21, 2020
Depressive Disorder, Major Trial in Worldwide (Esketamine 28 mg, Esketamine 56 mg, Esketamine 84 mg)
Completed
- Depressive Disorder, Major
- Esketamine 28 mg
- +6 more
-
Ciudad Autonoma de Buenos Aires, Argentina
- +170 more
Sep 13, 2022
Haemorrhage Between Vortioxetine Tablet Treatment and Selective
Not yet recruiting
- Major Depressive Disorder
- Vortioxetine Tablet
- SSRI
- (no location specified)
Jun 28, 2023
Selective Serotonin Reuptake Inhibitor on Cognition, Sexual
Recruiting
- Menopause
- Hormone replacement therapy
- Selective serotonin reuptake inhibitors
-
São Bernardo do Campo, SP, BrazilCentro de Atenção Integral à Saúde da Mulher
Jan 20, 2022
Bipolar Disorder, Major Depression Trial in Cleveland (Selective Serotonin Reuptake Inhibitor (SSRI))
Completed
- Bipolar Disorder
- Major Depression
- Selective Serotonin Reuptake Inhibitor (SSRI)
-
Cleveland, OhioCleveland Clinic Foundation Center for Behavioral Health
Nov 26, 2019
Obesity, Depression Trial in Lucerne (Roux-en-Y gastric bypass, sleeve gastrectomy)
Completed
- Obesity
- Depression
- Roux-en-Y gastric bypass, sleeve gastrectomy
-
Lucerne, SwitzerlandLuzerner Kantonsspital
Jun 9, 2021
Depressive Disorder, Major Trial in Worldwide (Esketamine, SSRI/SNRI)
Active, not recruiting
- Depressive Disorder, Major
-
Ciudad Autonoma de Buenos Aires, Argentina
- +58 more
Jan 31, 2023
Generalized Anxiety Disorder Trial in Kingston (SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and
Completed
- Generalized Anxiety Disorder
- SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and Norepinephrine Reuptake Inhibitors)
- Electronic Cognitive Behavioural Therapy
-
Kingston, Ontario, CanadaHotel Dieu Hospital
Sep 7, 2021
DaTSCAN Brain Scintigraphy and Psychotropic Treatments:
Not yet recruiting
- Parkinson Disease
- scintigraphy DaTSCAN
-
Vandœuvre-lès-Nancy, FranceCHRU Nancy
Jan 5, 2023
Depressive Disorder, Head Neck Cancer Trial in Birmingham (Venlafaxine)
Not yet recruiting
- Depressive Disorder
- Head and Neck Cancer
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Apr 26, 2022
Antidepressants in Advance of Investigational Trials
Recruiting
- Major Depressive Disorder
- FDA-approved selective-serotonin reuptake inhibitors (SSRIs) and selective-norepinephrine reuptake inhibitors (SNRIs)
-
Watertown, MassachusettsAdams Clinical
Mar 9, 2021
Depressive Disorder, Major, Anhedonia Trial in Worldwide (Aticaprant, Placebo)
Recruiting
- Depressive Disorder, Major
- Anhedonia
- Aticaprant
- Placebo
-
Birmingham, Alabama
- +156 more
Jan 31, 2023
Geriatric Depression, Cognitive Impairment Trial in Beijing (Selective Serotonin Reuptake Inhibitor(SSRIs,Fluoxetine,
Recruiting
- Geriatric Depression
- Cognitive Impairment
- Selective Serotonin Reuptake Inhibitor(SSRIs,Fluoxetine, paroxetine, fluvoxamine, sertraline, citalopram, escitalopram)
-
Beijing, ChinaBeijing Anding Hospital Affiliated to Capital Medical University
Oct 18, 2022
Depressive Disorder, Major, Treatment Resistant Depression, Melancholia Trial in Ghent (device, behavioral, drug)
Recruiting
- Depressive Disorder, Major
- +2 more
- aiTBS
- +2 more
-
Ghent, East-Flanders, BelgiumUniversity Hospital Ghent
Dec 6, 2022